PPA
RPTX

Parametric Portfolio Associates’s Repare Therapeutics RPTX Stock Holding History

Parametric Portfolio Associates’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$804K Buy
+56,439
New +$837K ﹤0.01% 2880

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

Parametric Portfolio Associates's RPTX Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Repare Therapeutics (RPTX) in Q1 2022: 56,439 shares worth $804K. The stake represents ﹤0.01% of the portfolio and ranks #2880 among its holdings.

62 funds tracked by Wall St. Rank hold RPTX as of Q1 2022.

  • Parametric Portfolio Associates held 56,439 shares of Repare Therapeutics worth $804K as of Q1 2022.
  • Repare Therapeutics was a new Parametric Portfolio Associates position in Q1 2022.
  • Repare Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2880 holding.
  • 62 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.